Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Aktuell zu Ihren Aktien: YOC (Boersengefluester) +++ YOC Aktie -3,36%

OPTIMI HEALTH Aktie

 >OPTIMI HEALTH Aktienkurs 
0.113 EUR    (Tradegate)
Ask: 0.122 EUR / 32627 Stück
Bid: 0.104 EUR / 38611 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>OPTIMI HEALTH Performance
1 Woche: +5,7%
1 Monat: -20,1%
3 Monate: -4,7%
6 Monate: -20,9%
1 Jahr: -48,4%
laufendes Jahr: -27,1%
>OPTIMI HEALTH Aktie
Name:  OPTIMI HEALTH CORP.
Land:  Kanada
Sektor:  Konsumgueter / Gastronomie
ISIN/ Wkn:  CA68405H1001 / A2QQEL
Symbol/ Ticker:  8BN (Frankfurt)
Kürzel:  FRA:8BN, ETR:8BN, 8BN:GR
Index:  -
Webseite:  https://optimihealth.ca/
Marktkapitalisierung:  9.52 Mio. EUR
Umsatz:  0.43 Mio. EUR
EBITDA:  -3.56 Mio. EUR
Gewinn je Aktie:  -0.035 EUR
Schulden:  2.45 Mio. EUR
Liquide Mittel:  0.05 Mio. EUR
Umsatz-/ Gewinnwachstum:  -26.1% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  26.09 / 1.55 / -
Gewinnm./ Eigenkapitalr.:  - / -48.35%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  OPTIMI HEALTH
Letzte Datenerhebung:  25.06.25
>Eigentümer
Aktien: 96.64 Mio. St.
f.h. Aktien: 75.7 Mio. St.
Insider Eigner: 16.18%
Instit. Eigner: -
Leerverk. Aktien: -
>Peer Group

 
08.05.25 - 13:06
 Optimi Health Corp.: Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of ......
05.05.25 - 13:42
 Optimi Health Corp.: Optimi Health Obtains U.S. FDA Drug Establishment Registration (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psiloc......
12.03.25 - 12:42
 Optimi Health Corp.: Optimi Health Provides Corporate Update (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed manu......
29.01.25 - 13:42
 Optimi Health Corp.: Optimi Health Completes Largest MDMA Capsule Batch to Date, Expands Stability Program (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - January 29, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian-based company licensed by Healt......
29.01.25 - 03:07
 Optimi Health Corp.: Optimi Health Announces Closing of Non-Brokered Private Placement and Debt Settlement (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - January 28, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psy......
17.01.25 - 23:06
 Optimi Health Corp.: Optimi Health Provides Corporate Update (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psy......
13.01.25 - 13:42
 Optimi Health Corp.: Optimi Health Reports First Patients Dosed in Landmark Natural Psilocybin Study in New Zealand (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - January 13, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of p......
06.01.25 - 13:42
 Optimi Health Corp.: Optimi Health Completes Second MDMA Shipment to Australia and Expands 2025 Production Forecast to Support Over 5,000 Patients Globally (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of ps......
17.12.24 - 13:48
 Optimi Health Corp.: Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed′s Phase IIb Palliative Care Trial (Newsfile)
 
Agreement Supports Phase IIb and Future Phase III Trial Development,Addressing Critical Needs in Palliative Care Using Optimi's Natural Psilocybin ExtractVancouver, British Columbia--(Newsfile Cor......
10.12.24 - 15:12
 Psyence Biomedical stock soars on binding agreements with Optimi Health (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.12.24 - 13:33
 Psyence Biomed Executes Binding Agreements with Optimi Health Corp. (GlobeNewswire EN)
 
Psyence Biomed obtains exclusive worldwide supply rights to Optimi's GMP-certified, nature-derived psilocybin for its drug development and commercialization initiatives in Palliative Care Psyence Biomed obtains exclusive worldwide supply rights to Optimi's GMP-certified, nature-derived psilocybin for its drug development and commercialization initiatives in Palliative Care...
23.10.24 - 13:51
 Optimi Health Corp.: Optimi Health Announces First PTSD Patients Treated with MDMA Capsules in Australia (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - October 23, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of p......
21.10.24 - 14:18
 Optimi Health CEO William Ciprick steps down, appoints Dane Stevens as interim CEO (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.10.24 - 13:42
 Optimi Health Corp.: Optimi Health Announces Leadership Transition (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed ma......
28.08.24 - 13:48
 Optimi Health Corp.: Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed man......
16.08.24 - 13:48
 Optimi Health Corp.: Optimi Health Completes Inaugural Export of MDMA Capsules to Australia for PTSD Treatment (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - August 16, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada-licensed psyc......
13.08.24 - 13:48
 Optimi Health Corp.: Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development (Newsfile)
 
Vancouver, British Columbia and New York, New York--(Newsfile Corp. - August 13, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi"), a GMP-approved, Health Canada license......
13.08.24 - 13:33
 Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development (GlobeNewswire EN)
 
VANCOUVER, British Columbia and NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi”), a GMP-approved, Health Canada licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, and Psyence Biomedical Ltd. (NASDAQ: PBM) (“Psyence”), a developer of nature-derived psilocybin-based therapeutics, are pleased to announce that the companies have entered into a non-binding Letter of Intent (“LOI”). This arrangement would position Optimi as the exclusive supplier of GMP nature-derived (non-synthetic) psilocybin extract for Psyence's global drug development and commercialization initiatives for FDA-approved use in the Palliative Care context....
07.08.24 - 14:48
 Optimi Health Corp.: Optimi Health Announces Non-Brokered Private Placement (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - August 7, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psych......
23.07.24 - 14:42
 Optimi Health Corp.: Optimi Health to Enter Asian Market with PsiloThai Collaboration on Psilocybin Research (Newsfile)
 
Vancouver, British Columbia--(Newsfile Corp. - July 23, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psyche......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!